Summary & Overview
HCPCS Level II C8013: Removal of Hypoglossal Neurostimulator Components
HCPCS Level II code C8013 denotes the removal of hypoglossal nerve neurostimulator electrode arrays and receiver. This explant procedure is relevant nationally as the use of neurostimulation devices for conditions such as obstructive sleep apnea increases and lifecycle management of implanted devices becomes more common. Explant codes affect clinical workflow, surgical scheduling, and device management policy across payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations, standard sites of service, and the clinical context for device explantation. The report summarizes typical procedural settings and highlights areas where payers often define medical necessity and benefit category distinctions for implanted device removal.
The publication provides benchmarks and policy context for billing and reimbursement of explant procedures, notes where coding clarity is important for claims processing, and identifies common operational implications for hospitals and ambulatory surgery centers. Data not available in the input is explicitly noted where applicable.
Billing Code Overview
HCPCS Level II code C8013 describes removal of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver. This procedure involves explantation of implanted neurostimulation hardware targeting the hypoglossal nerve, which is used in the management of certain obstructive sleep apnea therapies and other neuromodulation indications.
Service type: Surgical removal of implanted neurostimulator components.
Typical site of service: Ambulatory surgery center or hospital operating room, depending on patient complexity and anesthesia needs.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a middle-aged adult who previously received an implanted hypoglossal nerve neurostimulator for treatment of obstructive sleep apnea (OSA) and now requires complete removal of the device due to infection, device malfunction, pain, erosion, or patient preference. The clinical workflow begins with preoperative evaluation in the sleep surgery or otolaryngology clinic, including review of device records, imaging if indicated, and optimization of medical comorbidities. Preoperative antibiotics are given when infection is suspected. The procedure is performed in an operating room under general anesthesia with endotracheal intubation. A surgical exposure is made to the submandibular/subplatysmal pocket and along the path of the lead to the hypoglossal nerve. The generator/receiver is explanted from the subcutaneous pocket; lead(s) and electrode array(s) are dissected free and removed from the hypoglossal nerve. Hemostasis is achieved, and wounds are closed in layers. Postoperative care includes monitoring for airway compromise, pain control, wound care, and follow-up for culture results if infection was present. Documentation should specify the device components removed (electrode array(s), lead(s), and receiver), laterality if applicable, presence of infection, and any complications or retained fragments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | Use when the removal procedure is distinct/separate from other services on the same date (e.g., unrelated concurrent procedures). |